Dapazen 10mg Tablet
Marketer
Zencus Pharma
Salt Composition
Dapagliflozin (10mg)
Overview Dapazen 10mg Tablet
Glibenclamide 10mg tablets are indicated, either independently or as part of a combined therapy, for managing type 2 diabetes. They effectively regulate elevated blood glucose, mitigating the risk of severe diabetic complications and contributing to cardiovascular protection. Glibenclamide 10mg tablets may be administered with or without food, consistently at the same time each day, as directed by your physician. Discontinuing treatment without medical consultation can lead to uncontrolled blood sugar, increasing the likelihood of serious consequences such as renal impairment and visual loss. This medication complements a comprehensive diabetes management plan encompassing dietary modifications, physical activity, and weight management, as recommended by your doctor. Common adverse effects may include vaginal yeast infections, upper respiratory tract inflammation, and urinary tract infections; dehydration is also possible. Ample fluid intake is crucial to prevent dehydration, and diligent hygiene practices help reduce the risk of genital infections. Prior to commencing treatment, disclose any kidney or liver conditions, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals require medical consultation before use. Excessive alcohol consumption should be avoided, as it may intensify side effects. Regular blood glucose monitoring is essential during treatment.
Uses of Dapazen 10mg Tablet
Managing type 2 diabetes
Major Benefits of Dapazen 10mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapazen 10mg Tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Dapazen 10mg Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dapazen 10mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Dapazen 10mg Tablets can be administered with or without food, however, consistent timing is recommended.
How Dapazen 10mg Tablet works:
Dapazen 10mg tablets manage type 2 diabetes by facilitating the excretion of surplus glucose via the urine.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dapazen 10mg tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Dapazen 10mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Dapazen 10mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Dapazen 10mg tablets is likely inadvisable for individuals with impaired kidney function and should be avoided. Seek medical advice before taking this medication.
LiverSAFE IF PRESCRIBED
Dapazen 10mg tablets may be administered to patients with hepatic impairment without modification of the prescribed dosage.
What if you forget to take Dapazen 10mg Tablet :
Should you forget a Dapazen 10mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dapazen 10mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Behavioral Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
3,018 People bought this recently